GEHC|Analyst Targets
GEHC|Company Info
GEHC|Insider Trading
GEHC|Fundamentals
GEHC|Earnings Snapshot
EPS
| Qtr | Est | Actual | +/− |
|---|---|---|---|
| Q3'26 | $1.20 | - | - |
| Q2'26 | $1.04 | $1.13 | +9.1% |
| Q1'26 | $1.05 | $0.99 | -5.7% |
| Q4'25 | $1.43 | $1.44 | +1.0% |
| Q3'25 | $1.05 | $1.07 | +2.2% |
| Q2'25 | $0.92 | $1.06 | +15.4% |
Revenue
| Qtr | Est | Actual | +/− |
|---|---|---|---|
| Q3'26 | $5.5B | - | - |
| Q2'26 | $5.4B | $5.3B | -1.4% |
| Q1'26 | $5.0B | $5.1B | +2.1% |
| Q4'25 | $5.7B | $5.7B | -0.4% |
| Q3'25 | - | $5.1B | - |
| Q2'25 | - | $5.0B | - |
GEHC|Monthly Returns
Market Data
GEHC Stock Snapshot
- Market cap
- 29.69B
- P/E ratio
- 15.0
- Day range
- $64.03 – $65.44
- News sentiment
- 56/100 · Neutral
- Analyst target
- $83.05 (+28.3%)
- Consensus
- Buy · 30 analysts
GEHC is in a holding pattern - neither trend nor momentum has taken control. The stock is liquid enough that positioning changes get absorbed without distorting the trend.
Reverse DCF
What growth is priced into GEHC?
At today's price, GE HealthCare Technologies Inc. needs to grow free cash flow about 9.7% a year for the next 10 years to justify its valuation at a 8.44% cost of capital. Over its actual history it has compounded free cash flow at 0.4% a year, so the market is asking for 9.3 percentage points above its own delivered rate. On that basis GEHC looks priced above what its own growth record supports.
- Implied FCF growth
- 9.7%
- Historical FCF CAGR
- 0.4%
- Growth gap
- +9.3 pts
- Verdict
- RICH
- Discount rate (WACC)
- 8.44%
- Beta
- 0.98
Behaviour On Record
What GEHC's own history says about today's numbers
- Realized volatility (21d)
- 24.7% 35th pct
- Below its peak
- -30.1%
- vs 200-day average
- -7.8%
- Up days (1y)
- 50%
GE HealthCare Technologies Inc. is currently running 24.7% annualised volatility over the last 21 sessions. Measured against GEHC's own 4 years of daily returns rather than a market-wide average, that is the 35th percentile — on the quiet side for this stock, against a typical reading of 28.7%. The distinction matters because a number that looks calm for one stock is turbulent for another, and the absolute figure on its own tells you neither.
GEHC is trading -30.1% below its running peak. Across 3 full years on file, its median worst-drawdown-in-a-year was -27.6%, and the deepest was -37.8% in 2025. The current drawdown is already deeper than this stock's typical annual low point, which puts it in the part of its range where past recoveries began — and where past declines also continued.
Price sits -7.8% from its 200-day moving average. Against every other day in its history, that gap ranks at the 25th percentile — a narrower gap than it typically runs. Over the past year GEHC closed higher on 50% of sessions, and it is currently 2 sessions into a rising streak.
Overnight risk is measurable too: GEHC has opened more than 2% away from the prior close in 20 of 952 sessions (2.1% of the time), with the largest gaps running +6.6% and -6.6%. For anyone holding through an event, that rate is a better guide to overnight exposure than the intraday range.
Across the last 3 dated reports on file, GEHC moved an average of 2.3% in the session after earnings, closing higher 2 of those 3 times, with a median move of +1.5% and a largest of -2.8%.
All figures computed from 953 daily closes between 2022-12-15 and 2026-10-05, split-adjusted, recomputed daily. Percentiles are against GEHC's own 4-year history, not a peer group or index.
Sector Rotation
Is money rotating into or out of GEHC's sector?
GE HealthCare Technologies Inc. sits in the Health Care sector, currently ranked 3rd of 12 GICS sectors by relative-strength rotation score (weakening).
- Sector rank
- #3 of 12
- Sector state
- Weakening
- Sector rotation score
- 82
Analyst Rating Changes
Are analysts turning bullish or bearish on GEHC?
Needham most recently initiated coverage on GE HealthCare Technologies Inc. to Buy on Sep 22, 2026 with a price target of $93. Over the last 90 days, coverage has run 0 upgrades against 0 downgrades, a net mixed lean.
- Latest action
- Needham — Buy
- 90-day upgrades
- 0
- 90-day downgrades
- 0
- Net rating momentum
- 0
GEHC Competitive Positioning
- GEHCyou're hereGE HealthCare Technologies Inc.$29.7B-0.05%
- MDTMedtronic plc$112.3B-0.57%
- BSXBoston Scientific Corporation$62.1B+0.45%
- EWEdwards Lifesciences Corporation$50.1B-0.02%
- ZBHZimmer Biomet Holdings, Inc.$17.5B-0.09%
- PODDInsulet Corporation$9.4B+0.49%
Held by These ETFs
News Sentiment Analysis
Sentiment gathered from recent headlines
Recent News Coverage
Most recent articles, ranked by recency (click to expand).
Technical Analysis
Real-time indicators across multiple timeframes
| Manager | Trend | Shares Held | % of Co. | Position Value | Filed |
|---|---|---|---|---|---|
| Vanguard Group Inc | ▲ Buy | 52,275,767 | 11.38% | $4.29B | 2026-01-29 |
| BlackRock, Inc. | ▲ Buy | 37,467,843 | 8.16% | $2.40B | 2026-08-07 |
| Invesco Ltd. | ▲ Buy | 18,296,350 | 3.98% | $1.17B | 2026-08-14 |
| Harris Associates L P | ▼ Sell | 15,329,664 | 3.34% | $981.25M | 2026-08-14 |
| JPMorgan Chase & Co | ▲ Buy | 10,329,264 | 2.25% | $671.92M | 2026-08-12 |
| Morgan Stanley | ▼ Sell | 6,223,322 | 1.35% | $398.36M | 2026-08-13 |
| Norges Bank | ▼ Sell | 5,823,524 | 1.27% | $372.76M | 2026-08-12 |
| Goldman Sachs Group Inc | ▲ Buy | 4,446,565 | 0.97% | $284.62M | 2026-08-14 |
| Northern Trust Corp | ▼ Sell | 3,938,748 | 0.86% | $252.12M | 2026-08-13 |
| Bank of America Corp | ▼ Sell | 3,249,771 | 0.71% | $208.02M | 2026-08-14 |
| FMR LLC (Fidelity) | ▲ Buy | 3,155,095 | 0.69% | $201.96M | 2026-08-13 |
| Trian Fund Management, L.P. | ▲ Buy | 3,085,344 | 0.67% | $197.49M | 2026-08-12 |
| Citadel Advisors LLC | • Hold | 3,051,632 | 0.66% | $195.33M | 2026-09-02 |
| Temasek Holdings (Private) Ltd | ▼ Sell | 2,515,393 | 0.55% | $161.01M | 2026-08-07 |
| D1 Capital Partners L.P. | ▲ Buy | 1,763,284 | 0.38% | $144.62M | 2026-02-17 |
| Susquehanna International Group, LLP | ▲ Buy | 1,464,067 | 0.32% | $93.71M | 2026-08-14 |
| Point72 Asset Management, L.P. | ▲ Buy | 1,457,873 | 0.32% | $93.32M | 2026-08-14 |
| Wells Fargo & Company | ▼ Sell | 879,516 | 0.19% | $56.30M | 2026-08-14 |
| Citigroup Inc | ▲ Buy | 850,374 | 0.19% | $54.43M | 2026-08-03 |
| AQR Capital Management LLC | ▲ Buy | 696,084 | 0.15% | $44.33M | 2026-08-14 |
| Suvretta Capital Management, LLC | • Hold | 532,280 | 0.12% | $39.43M | 2025-08-14 |
| Squarepoint Ops LLC | ▲ Buy | 601,731 | 0.13% | $38.52M | 2026-08-14 |
| Gotham Asset Management, LLC | ▲ Buy | 584,395 | 0.13% | $37.41M | 2026-08-14 |
| AllianceBernstein L.P. | ▼ Sell | 518,346 | 0.11% | $36.90M | 2026-08-14 |
| D. E. Shaw & Co., Inc. | ▼ Sell | 418,089 | 0.09% | $26.76M | 2026-08-14 |
| Member | Chamber | State | Type | Amount | Traded | Filed |
|---|---|---|---|---|---|---|
| Alan Armstrong | Senate | OK | ▲ Buy | $1K - $15K | 2026-03-27 | 2026-07-21 |
| Terri A. Sewell | House | AL07 | ▼ Sell | $1K - $15K | 2026-03-25 | 2026-04-21 |
| Warren Davidson | House | OH08 | ▼ Sell | $1K - $15K | 2026-03-23 | 2026-03-25 |
| Rob Bresnahan | House | PA08 | ▲ Buy | $1K - $15K | 2025-05-15 | 2025-05-31 |
| Rob Bresnahan | House | PA08 | ▼ Sell | $1K - $15K | 2025-04-08 | 2025-04-28 |
| Austin Scott | House | GA08 | ▼ Sell | $1K - $15K | 2025-03-27 | 2025-08-13 |
| Rob Bresnahan | House | PA08 | ▲ Buy | $1K - $15K | 2025-02-25 | 2025-03-27 |